SCHEMBL7583269

SCHEMBL7583269

CSCCC(C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6344243 0.75 ALDH1A1 (0.53)
SCHEMBL74466 0.73
SCHEMBL27343046 0.73
SCHEMBL979808 0.73
SCHEMBL37987 0.71 ALDH1A1 (1.00)
SCHEMBL7578673 0.71
SCHEMBL6346189 0.71 ALDH1A1 (0.47)
SCHEMBL19604240 0.69
SCHEMBL23109118 0.69 ALDH1A1 (0.45)
SCHEMBL10973808 0.69 TDP1 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116848113-A Bicyclic compounds as HPK1 inhibitors and application thereof 南京再明医药有限公司 2023-10-03 CN disclosed
WO-2022171034-A1 BICYCLIC COMPOUND AS HPK1 INHIBITOR AND APPLICATION THEREOF 江苏先声药业有限公司 2022-08-18 WO disclosed
US-8987195-B2 HCV NS3 protease inhibitors MERCK SHARP & DOHME CORP. (US) 2015-03-24 US disclosed
US-8987195-B2 HCV NS3 protease inhibitors MERCK SHARP & DOHME CORP. (US) 2015-03-24 US disclosed
US-20140057836-A1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2014-02-27 US disclosed
US-20140057836-A1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2014-02-27 US disclosed
WO-2014025736-A1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-02-13 WO disclosed
WO-2002094771-A1 PROCESS FOR THE PRODUCTION OF A SULPHUR-CONTAINING COMPOUND ADISSEO FRANCE S.A.S. (FR) 2002-11-28 WO disclosed
EP-1260500-A1 Process for the production of a sulphur-containing organic compound AVENTIS ANIMAL NUTRITION S.A. (FR) 2002-11-27 EP disclosed